Innovision IPO Day 4: Issue booked 30% so far, price band cut to ₹494-519 apiece. GMP trades flat. Apply or not?
Analysis of this story by livemint_markets · 13 Mar 2026, 8:39 AM IST (about 2 months ago)
AI Analysis
IPO market sentiment is influenced by subscription levels and grey market premiums. A flat GMP often suggests a listing close to the issue price.
Trading Insight
For IPOs with flat GMP, short-term listing gain opportunities are limited. Focus on the company's fundamentals for long-term investment decisions.
Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
Key Evidence
- •Innovision IPO subscription is 30% on Day 4.
- •The price band has been cut to ₹494-519 apiece.
- •QIBs have shown a strong response.
- •GMP is trading flat.
- •Risk flag: Lower than expected subscription.
Sectors:pharma
Sources and updates
Original source: livemint_markets
Published: 13 Mar 2026, 8:39 AM IST
Last updated on Anadi News: 13 Mar 2026, 9:00 AM IST
AI-powered analysis by
Anadi Algo News